Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What fueled the previous growth in the digital genome market?

The size of the digital genome market has seen a rapid increase in recent years. The market, which is projected to grow from $39.25 billion in 2024, is expected to hit $46.94 billion in 2025, reflecting a compound annual growth rate (CAGR) of 19.6%. Factors contributing to this growth during the historic period include the increased funding for genomics, the decreased cost and faster pace of DNA sequencing, the emergence of new entrants and start-ups in developing economies, the increasing number of drug discoveries, and the expansion of the biotech sector.

What will be the digital genome market size in the future?

The size of the digital genome market is forecasted to experience a swift increase in the coming years, swelling to $97.13 billion by 2029 with a CAGR of 19.9%. The predicted growth during this period could be due to several factors such as the increasing occurrence of genetic maladies, the exponential increase in research and development in the field of the digital genome, the burgeoning acceptance of personalized medicine, advancements in biotechnology, and the growing prevalence of chronic illnesses. Noteworthy trends expected throughout this forecast period include the expanding use of next-gen sequencing technologies, growing technological breakthroughs, the comprehensive usage of microorganisms in the diagnostic industry, a rising demand for tailored medicines, and an increase in the uptake of digital genomic technology by healthcare institutions and clinics.

Get your digital genome market report here!

https://www.thebusinessresearchcompany.com/report/digital-genome-global-market-report

What main drivers are fueling expansion in the digital genome market?

The growing occurrence of genetic ailments is predicted to fuel the expansion of the digital genome market in the future. Genetic disorders are inherited diseases resulting from abnormalities or changes in an individual’s DNA – the genetic blueprint that oversees the body’s development and operation. Digital genome technologies facilitate the detection of these genetic changes and variations linked to genetic illnesses. This data supports precise and early detection of these ailments, resulting in prompt intervention and treatment. For example, the National Library of Medicine, a medical library based in the US, noted in August 2023 that sickle cell anemia, a genetic malady, affects roughly 1 in 500 African Americans. Moreover, around 1 in 12 African Americans possesses the autosomal recessive mutation causing the disease, with around 300,000 infants being born with sickle cell anemia annually. Consequently, this increase in genetic disorders is propelling the progress of the digital genome market.

What key areas define the segmentation of the global digital genome market?

The digital genome market covered in this report is segmented –

1) By Type: Sequencing And Analyzer Instruments, Data Analysis And Management Tools

2) By Application: Diagnostics, Agriculture And Animal Research, Personalized Medicine, Drug Discovery, Treatment Analysis

3) By End User: Research Centers And Government Institutes, Academic Institutions, Pharmaceutical And Biotechnology Industries, Hospitals, Diagnostic Centers

Subsegments:

1) By Sequencing And Analyzer Instruments: Next-Generation Sequencing (NGS) Systems, Sanger Sequencing Systems, Single-Cell Sequencing Instruments, Third-Generation Sequencing Instruments

2) By Data Analysis And Management Tools: Bioinformatics Software, Data Management Platforms, Cloud-Based Analysis Solutions, Workflow Management Tools

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14086&type=smp

Who are the dominant players expanding their reach in the digital genome market?

Major companies operating in the digital genome market are Roche Holding AG, Thermo Fisher Scientific Inc., GE HealthCare Technologies Inc., Quest Diagnostics, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., bioMerieux SA, PerkinElmer Inc., Bio-Rad Laboratories Inc., Qiagen N.V., BGI Genomics, Myriad Genetics Inc., Foundation Medicine Inc., ArcherDx Inc., Invitae Corporation, Oxford Nanopore Technologies Ltd., Luminex Corporation, GenMark Diagnostics Inc., NanoString Technologies Inc., Pacific Biosciences of California Inc., Genewiz, Inscripta Inc., Genomic Health Inc., Becton Dickinson and Company, GenomeMe, Regeneron Pharmaceuticals Inc.

How are evolving market trends shaping digital genome Strategies?

The digital genome market’s significant players are introducing unique products such as the NovaSeq X Series to comprehend illnesses and significantly enhance patient outcomes. The NovaSeq X Series incorporates the NovaSeq X and NovaSeq X Plus systems, with the latter capable of sequencing over 128 genomes per run and creating more than 20,000 complete genomes annually. In September 2022, Illumina, Inc., an American biotechnology firm, unveiled the NovaSeq X Series, marking a substantial leap in whole-genome sequencing technology. The system includes cost-effectiveness throughout the process, simplified informatics, operational simplicity, advancements in sustainability, and superior support. It broadens and deepens sequencing, empowers users to expand any application to cover additional samples, and improves data analysis efficiency. The NovaSeq X series is engineered to be the most powerful and cost-efficient sequencing system, and includes enhanced reagent stability and speedy data transfers due to streamlined genetics data compression. Remarkably, the system has been specially designed for improved sustainability by minimizing the data footprint, which in turn lowers storage and energy expenses.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=14086

Which regions are emerging as leaders in the digital genome market?

North America was the largest region in the digital genome market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the digital genome market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Digital Multimeter Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/digital-multimeter-global-market-report

Digital Battlefield Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/digital-battlefield-global-market-report

Digital Therapeutics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/digital-therapeutics-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: